selected publications
- Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE. BMC nephrology. 2022 Academic Article GET IT
- Dose effect analysis of sodium zirconium cyclosilicate in hemodialysis patients. Hemodialysis international. International Symposium on Home Hemodialysis. 2021 Letter GET IT
-
Effectiveness of Sodium Zirconium Cyclosilicate in Hemodialysis Patients With Severe Hyperkalemia.
Kidney international reports.
2021
Academic Article
GET IT
Times cited: 84 -
Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis Setting.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
2021
Academic Article
GET IT
Times cited: 4 -
Hypoxia-Inducible Factor Stabilization as an Emerging Therapy for CKD-Related Anemia: Report From a Scientific Workshop Sponsored by the National Kidney Foundation.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2021
Academic Article
GET IT
Times cited: 8 - Erratum to: Sodium Zirconium Cyclosilicate Increases Serum Bicarbonate Concentrations Among Patients with Hyperkalaemia: Exploratory Analyses from Three Randomized, Multi-Dose, Placebo-Controlled Trials. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2021 Article GET IT
-
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.
The New England journal of medicine.
2021
Academic Article
GET IT
Times cited: 69 -
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
The New England journal of medicine.
2021
Academic Article
GET IT
Times cited: 90 -
Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trials.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2021
Academic Article
GET IT
Times cited: 12 -
Treatment of anemia in difficult-to-manage patients with chronic kidney disease.
Kidney international supplements.
2021
Academic Article
GET IT
Times cited: 11 -
Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2021
Academic Article
GET IT
Times cited: 28 -
Clinical Management of Hyperkalemia.
Mayo Clinic proceedings.
2020
Review
GET IT
Times cited: 48 -
Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data.
BMC nephrology.
2020
Academic Article
GET IT
Times cited: 28 -
Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review.
PharmacoEconomics - open.
2019
Review
GET IT
Times cited: 15 -
Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE.
American journal of nephrology.
2019
Academic Article
GET IT
Times cited: 35 -
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2019
Academic Article
GET IT
Times cited: 23 -
A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.
Journal of the American Society of Nephrology : JASN.
2019
Academic Article
GET IT
Times cited: 79 -
Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease.
Kidney international reports.
2019
Academic Article
GET IT
Times cited: 6 -
Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study.
Clinical journal of the American Society of Nephrology : CJASN.
2019
Academic Article
GET IT
Times cited: 102 -
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.
Kidney international.
2019
Academic Article
GET IT
Times cited: 23 -
Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review.
Journal of medical economics.
2019
Academic Article
GET IT
Times cited: 50 -
Alectinib (Alecensa)-induced reversible grade IV nephrotoxicity: a case report and review of the literature.
Journal of medical case reports.
2018
Review
GET IT
Times cited: 13 -
Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease.
Journal of diabetes and its complications.
2018
Academic Article
GET IT
Times cited: 14 -
Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2018
Review
GET IT
Times cited: 145 -
One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2017
Academic Article
GET IT
Times cited: 14 -
Pernicious Anemia Associated Cobalamin Deficiency and Thrombotic Microangiopathy: Case Report and Review of the Literature.
2017
GET IT
Times cited: 53 -
Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease.
Kidney international.
2016
Academic Article
GET IT
Times cited: 161 -
Hypoxia-Inducible Factor Stabilizers: a New Avenue for Reducing BP While Helping Hemoglobin?.
Current hypertension reports.
2016
Review
GET IT
Times cited: 16 -
Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal disease population unresponsive to primary vaccination series.
Renal failure.
2015
Review
GET IT
Times cited: 17 -
Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2015
Academic Article
GET IT
Times cited: 99 -
Novel Agents for the Prevention and Management of Hyperkalemia.
Reviews in cardiovascular medicine.
2015
Review
GET IT
Times cited: 20 -
Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial.
JAMA.
2014
Academic Article
GET IT
Times cited: 285 -
Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.
The New England journal of medicine.
2013
Academic Article
GET IT
Times cited: 84 - Early initiation of dialysis in patients with chronic progressive kidney failure does not confer a mortality advantage when compared with an approach of late initiation combined with appearance of symptoms or signs of uraemia. Evidence-based medicine. 2010 Comment GET IT
-
C.E.R.A. once every 4 weeks in patients with chronic kidney disease not on dialysis: The ARCTOS extension study.
Hemodialysis international. International Symposium on Home Hemodialysis.
2009
Academic Article
GET IT
Times cited: 32 -
Anaemia management with subcutaneous epoetin delta in patients with chronic kidney disease (predialysis, haemodialysis, peritoneal dialysis): results of an open-label, 1-year study.
BMC nephrology.
2009
Academic Article
GET IT
Times cited: 7 -
Ferumoxytol for treating iron deficiency anemia in CKD.
Journal of the American Society of Nephrology : JASN.
2008
Academic Article
GET IT
Times cited: 217 -
A randomized study of extended dosing regimens for initiation of epoetin alfa treatment for anemia of chronic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN.
2008
Academic Article
GET IT
Times cited: 33 -
Anemia management in patients on peritoneal dialysis: efficacy and safety of epoetin delta.
Haematologica.
2008
Academic Article
GET IT
Times cited: 4 -
C.E.R.A. maintains stable control of hemoglobin in patients with chronic kidney disease on dialysis when administered once every two weeks.
American journal of nephrology.
2007
Academic Article
GET IT
Times cited: 45 -
Epoetin delta is effective for the management of anaemia associated with chronic kidney disease.
Current medical research and opinion.
2006
Academic Article
GET IT
Times cited: 29 -
The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients.
Kidney international.
2005
Academic Article
GET IT
Times cited: 66 -
Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products.
Nephron. Clinical practice.
2004
Academic Article
GET IT
Times cited: 36 -
Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy.
American journal of nephrology.
2003
Academic Article
GET IT
Times cited: 386 -
Prediction of single-pool Kt/v based on clinical and hemodialysis variables using multilinear regression, tree-based modeling, and artificial neural networks.
Artificial organs.
2003
Academic Article
GET IT
Times cited: 4 -
Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2000
Academic Article
GET IT
Times cited: 121 -
Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).
Controlled clinical trials.
1999
Academic Article
GET IT
Times cited: 208 -
Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin therapy in chronic dialysis patients.
American journal of nephrology.
1998
Academic Article
GET IT
Times cited: 25 -
Potential angiotensin-converting enzyme inhibitor-epoetin alfa interaction in patients receiving chronic hemodialysis.
Pharmacotherapy.
1998
Academic Article
GET IT
Times cited: 13 -
Fluoxetine in depressed patients on dialysis.
International journal of psychiatry in medicine.
1997
Academic Article
GET IT
Times cited: 111 -
Fractional direct dialysis quantification: a new approach for prescription and monitoring hemodialysis therapy.
Kidney international.
1996
Academic Article
GET IT
Times cited: 19 -
Cholesterol crystal embolization-associated renal failure after therapy with recombinant tissue-type plasminogen activator.
1993
GET IT
Times cited: 36 -
Dialysis adequacy in hypoalbuminemic continuous ambulatory peritoneal dialysis patients.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
1993
Academic Article
GET IT
Times cited: 3 -
Dialysis adequacy versus metabolic factors in the clinical assessment of CAPD.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.
1993
Academic Article
GET IT
Times cited: 3 -
Impact of epoetin beta on dialyzer clearance and heparin requirements.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
1991
Academic Article
GET IT
Times cited: 20 -
Transfusion therapy: associated risks and alternative approaches.
ANNA journal.
1990
Academic Article
GET IT
Times cited: 1 -
EPO--one year later: a look at rehabilitation. The impact of long-term epoetin beta therapy on ESRD patient quality of life.
Nephrology news & issues.
1990
Academic Article
GET IT
Times cited: 4 -
Effect of long-term epoetin beta therapy on the quality of life of hemodialysis patients.
ASAIO transactions.
1990
Academic Article
GET IT
Times cited: 20 -
The practical aspects of therapy with rHuEPO.
American journal of nephrology.
1990
Academic Article
GET IT
Times cited: 1 -
The existence of a protracted course in crescentic glomerulonephritis.
Kidney international.
1987
Academic Article
GET IT
Times cited: 29 -
Subclavian vein stenosis as a complication of subclavian catheterization for hemodialysis.
Archives of internal medicine.
1987
Academic Article
GET IT
Times cited: 75 -
Comparison of eosinophilia in patients undergoing peritoneal dialysis and hemodialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
1986
Academic Article
GET IT
Times cited: 16 -
A comparative study of continuous ambulatory peritoneal dialysis and center hemodialysis. Efficacy, complications, and outcome in the treatment of end-stage renal disease.
Archives of internal medicine.
1986
Academic Article
GET IT
Times cited: 34 -
Nondilated obstructive nephropathy.
1983
GET IT
Times cited: 52 -
CAPD peritonitis in perspective.
Clinical and experimental dialysis and apheresis.
1982
Academic Article
GET IT
Times cited: 1 - Continuous ambulatory peritoneal dialysis: establishment and growth of a program in a large metropolitan area. Clinical and experimental dialysis and apheresis. 1982 Academic Article GET IT
-
Eosinophilic peritonitis.
Clinical and experimental dialysis and apheresis.
1982
Academic Article
GET IT
Times cited: 17 -
Technique for implantation of the Toronto-Western catheter at the Booth Memorial Medical Center.
Clinical and experimental dialysis and apheresis.
1982
Academic Article
GET IT
Times cited: 1 -
Dialysis eosinophilia.
Transactions - American Society for Artificial Internal Organs.
1981
Academic Article
GET IT
Times cited: 9 -
Action of adenosine on chloride active transport of isolated frog cornea.
The American journal of physiology.
1979
Academic Article
GET IT
Times cited: 17 -
Dialysance of iodide.
The New England journal of medicine.
1978
Letter
GET IT
Times cited: 1 -
Increased production of fructose by the brain in dogs made diabetic by alloxan and by growth hormone.
Diabetes.
1973
Academic Article
GET IT
Times cited: 3